David T. Miyamoto, M.D., Ph.D.
Affiliations: | 2011- | Harvard University, Cambridge, MA, United States | |
2011- | Massachusetts General Hospital, Boston, MA |
Area:
Circulating Tumor Cells, Prostate cancer, Bladder cancer, Biomarkers, Microtubules, Actin, Mitosis, Cell cycleGoogle:
"David Miyamoto"Parents
Sign in to add mentorTimothy J. Mitchison | grad student | 2004 | Harvard | |
(Probing the functions of kinesins in mitosis.) | ||||
Daniel A. Haber | post-doc | 2009-2017 | Harvard Medical School |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Karabacak NM, Zheng Y, Dubash TD, et al. (2022) Differential kinase activity across prostate tumor compartments defines sensitivity to target inhibition. Cancer Research |
Miyamoto DT, Lee RJ. (2020) PIK Carefully, AKT Accordingly: Towards Precision Medicine in Prostate Cancer. European Urology |
de Jong JJ, Boormans JL, van Rhijn BWG, et al. (2020) Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences. European Urology Oncology |
Fisher RR, Pleskow HM, Bedingfield K, et al. (2019) Noncanonical Wnt as a prognostic marker in prostate cancer: "You can't always get what you Wnt". Expert Review of Molecular Diagnostics |
Batista da Costa J, Gibb EA, Bivalacqua TJ, et al. (2019) Molecular characterization of neuroendocrine-like bladder cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Zheng Y, Comaills V, Burr R, et al. (2019) COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America |
Efstathiou JA, Mouw KW, Gibb EA, et al. (2019) Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-sparing Trimodality Therapy for Muscle-invasive Bladder Cancer. European Urology |
Costa JBD, Gibb EA, Bivalacqua TJ, et al. (2019) Molecular characterization of neuroendocrine-like bladder cancer European Urology Supplements. 18 |
Kamran S, Yeap B, Pleskow H, et al. (2019) Prospective Validation of Single Nucleotide Polymorphisms as Predictors of Rectal Toxicity Following Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 105: E284-E285 |
Hwang W, Pleskow H, Czapla JAA, et al. (2019) Integrated Gene Expression Score in Circulating Tumor Cells to Predict Treatment Response in Muscle-Invasive Bladder Cancer International Journal of Radiation Oncology*Biology*Physics. 105: E663 |